MyMyelomaTeam

"Low risk" myeloma refers to how likely the disease is to progress quickly or respond well to treatment. Doctors use a combination of factors to determine risk level, which helps guide treatment decisions.

Factors that generally point to a lower-risk profile include:

- Fewer abnormal plasma cells in the bone marrow
- Show Full Answer

"Low risk" myeloma refers to how likely the disease is to progress quickly or respond well to treatment. Doctors use a combination of factors to determine risk level, which helps guide treatment decisions.

Factors that generally point to a lower-risk profile include:

- Fewer abnormal plasma cells in the bone marrow
- Lower levels of serum free light chain (SFLC) proteins in the blood
- Favorable genetic markers within the myeloma cells
- Earlier stage at diagnosis

Lower-risk myeloma tends to respond better to treatment and may progress more slowly, which can mean a better outlook overall. It's worth knowing that risk levels can change over time, so regular monitoring is really important. Treatment in a specialist academic or cancer network center has also been linked to better outcomes, so it's always worth asking your care team whether a specialist referral makes sense for your situation.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

Multiple Myeloma Prognosis: Survival Rates, Light Chain, and More Factors

Multiple Myeloma Types and Related Conditions